Occurrence of hemolytic reactions on the same day as immune globulin product administrations during 2008 to 2014
Author:
Affiliation:
1. HealthCore, Inc; Alexandria Virginia
2. Center for Biologics Evaluation and Research, U.S. Food and Drug Administration; Silver Spring Maryland
Funder
U.S. Food and Drug Administration
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14384/fullpdf
Reference45 articles.
1. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology;Orange;J Allergy Clin Immunol,2006
2. Recommendations for the use of albumin and immunoglobulins;Liumbruno;Blood Transfus,2009
3. Unlabeled uses of intravenous immune globulin;Leong;Am J Health Syst Pharm,2008
4. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin;Kazatchkine;N Engl J Med,2001
5. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature;Darabi;Transfusion,2006
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis;Neurology and Therapy;2023-05-12
2. Hepatitis B virus-associated cryoglobulinaemia diffuse endocapillary proliferative glomerulonephritis: a case report and literature review;Journal of International Medical Research;2022-11
3. Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations;Transfusion;2022-08-02
4. An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG);Biologicals;2022-07
5. Two roads diverged: Emerging lessons from IVIG about hemolysis;Transfusion;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3